poly drug use - a challenge for drug treatment

نویسندگان

nadeem rehman regional coordinator, drug demand reduction and hiv, regional programme for afghanistan and neighbouring countries, unodc

چکیده

poly-drug use refers to the use of two or more substances at the one time or repeatedly. it is common among both recreational and regular drug users across the world. poly-drug use is a great contributor to the global number of deaths related to drug overdose. in this case, the likelihood of drug overdose and its pertaining complications in an individual is higher especially when benzodiazepines or alcohol is consumed along with other drugs. according to the recent who report, there are 3 patterns of poly-drug use: (1) different substances are taken together to have a cumulative or complementary effect, which is commonly seen among (a) cannabis or cocaine users (the drug may be used in combination with alcohol), (b) heroin users (the drug might be used in combination with benzodiazepines, alcohol or other opioids), (c) cocaine users (the drug might be used in combination with other stimulants); (2) the use of a drug to mitigate the adverse effects of another drug (e.g., use of cocaine and heroin or other opioids); (3) a drug is gradually replacing by another drug due to changes in price or availability (e.g., ecstasy is substituted by mephedrone or other psychoactive substances). opioids, alcohol, cannabis and cocaine are the most common substances implicated in poly-drug use in different parts of the world. the paradoxical or sometimes amplifying effects of drugs used concurrently make the treatment of the poly-drug use patients extremely challenging. it has been considered important to understand the patterns of poly-drug in different regions to prevent and modify the risk factors and to provide useful guidelines for physicians.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Poly Drug Use - A Challenge for Drug Treatment

Poly-drug use refers to the use of two or more substances at the one time or repeatedly. It is common among both recreational and regular drug users across the world. Poly-drug use is a great contributor to the global number of deaths related to drug overdose. In this case, the likelihood of drug overdose and its pertaining complications in an individual is higher especially when benzodiazepine...

متن کامل

Drug abuse among nurses: A neglected challenge

Drug dependence is a prominent issue in individuals of different professions, education levels, and socioeconomic classes. Authors of this paper, including the first author (as a qualified clinical nurse and nursing supervisor), aimed to address the challenges associated with substance abuse and the subsequent failure in interactions between healthcare personnel and patients referring to clinic...

متن کامل

Kinetoplast DNA: A Promising Drug Target for Treatment of Leishmaniasis

Leishmaniasis is a vector-borne zoonotic disease caused by various species of the genus Leishmania, (trypanosomatidae family) that is transmitted by phlebotomine sandflies. The disease can present in a range of clinical forms, including dermal lesions, metastasis mucocutaneous forms, and fatal visceral forms. In this non-systematic review, we aimed at introducing the role of kinetoplast DNA (kD...

متن کامل

The Readiness Ruler as a measure of readiness to change poly-drug use in drug abusers

Readiness to change is a crucial issue in the treatment of substance use disorders. Experiences with methadone maintenance treatment (MMT) has shown that continuous drug and alcohol use with all its consequences characterize most MMT programs. In a prospective study of drug abusers seeking opiate agonist maintenance treatment in the City of Copenhagen, subjects were administered the Addiction S...

متن کامل

Prodrugs: a challenge for the drug development.

It is estimated that about 10% of the drugs approved worldwide can be classified as prodrugs. Prodrugs, which have no or poor biological activity, are chemically modified versions of a pharmacologically active agent, which must undergo transformation in vivo to release the active drug. They are designed in order to improve the physicochemical, biopharmaceutical and/or pharmacokinetic properties...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
asia pacific journal of medical toxicology

جلد ۳، شماره Supplement ۱، صفحات ۱-۱

کلمات کلیدی

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023